FDA.reportPublic FDA data

EXCEDRIN

Product NDC
0067-2039
11-digit product format
000672039
Labeler code
0067
Product ID
0067-2039_7386648a-3c0a-4586-9b61-fd824edfdfc1
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Aspirin (NSAID) and Caffeine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Haleon US Holdings LLC
Application
NDA020802
Marketing category
NDA
Marketing start
2010-02-15
Substance
ACETAMINOPHEN; ASPIRIN; CAFFEINE
Active strength
250; 250; 65 mg/1; mg/1; mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0067-20390067-2039-07DDiscontinued by firm2026-08-07
excluded packagepackage0067-20390067-2039-08DDiscontinued by firm2026-08-07
excluded packagepackage0067-20390067-2039-09DDiscontinued by firm2026-08-07
excluded packagepackage0067-20390067-2039-84DDiscontinued by firm2026-08-07
excluded packagepackage0067-20390067-2039-86DDiscontinued by firm2026-08-07
excluded packagepackage0067-20390067-2039-94DDiscontinued by firm2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 82 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source datePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-050067-2039-84d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050067-2039-08d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050067-2039-09d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050067-2039-86d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050067-2039-94d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050067-2039-07d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-260067-2039-84f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260067-2039-08f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260067-2039-09f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260067-2039-86f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260067-2039-94f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260067-2039-07f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-310067-2039-862ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310067-2039-842ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310067-2039-072ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310067-2039-942ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310067-2039-082ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310067-2039-092ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-280067-2039-86a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280067-2039-84a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280067-2039-07a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280067-2039-94a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280067-2039-08a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280067-2039-09a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-210067-2039-86cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210067-2039-84cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210067-2039-07cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210067-2039-94cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210067-2039-08cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210067-2039-09cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-100067-2039-86cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100067-2039-84cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100067-2039-07cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100067-2039-94cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100067-2039-08cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100067-2039-09cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-310067-2039-86302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310067-2039-84302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310067-2039-07302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310067-2039-94302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310067-2039-08302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310067-2039-09302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-200067-2039-86ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200067-2039-84ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200067-2039-07ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200067-2039-94ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200067-2039-08ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200067-2039-09ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100067-2039-860efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100067-2039-840efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100067-2039-070efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100067-2039-940efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100067-2039-080efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100067-2039-090efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-080067-2039-86ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080067-2039-84ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080067-2039-07ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080067-2039-94ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080067-2039-08ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080067-2039-09ad56d346431e…cc804d4bbf1e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020802-001EXCEDRIN (MIGRAINE RELIEF)ACETAMINOPHEN; ASPIRIN; CAFFEINE250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-146a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-1403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-142680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-145bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-1479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-141e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-148072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-145c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-145d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-144b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-1474a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-1487673890dc5c…
2021-03-12 10:30 UTC2021-03N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-145aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-148869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-143f01610625f2…
2019-09-15 20:21 UTC2019-09N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14b00525d2431f…
2019-07-19 19:46 UTC2019-07N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-146a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-141c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-149b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020802-001EXCEDRIN (MIGRAINE RELIEF)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-143f0d92c62455…
2023-05-13 08:27 UTC2023-05N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14053a50430f4f…
2023-01-26 05:58 UTC2023-01N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-143bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-143a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020802-001EXCEDRIN (MIGRAINE)250MG;250MG;65MGTABLET / ORALRLD, RS1998-01-14cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
EXCEDRIN
Brand name suffix
MIGRAINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACETAMINOPHEN250 mg/1
ASPIRIN250 mg/1
CAFFEINE65 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
362O9ITL9DInternal UNII lookup
R16CO5Y76EInternal UNII lookup
3G6A5W338EInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
209468Internal RxNorm lookup
308297Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7ed841fb-a61c-4868-b4e5-4f2311a5e79cAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
75d4bef7-334c-4a95-abb5-bff9def24114Product name220260112
7dea7767-9f52-b60a-5435-33cb9cc28baeProduct name420250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4Product name720250116
11939cf5-0ea7-5df5-5127-00a7ce07fd7fProduct name520250115
0ca83774-3f79-b837-5d6f-c210102f3bc8Product name620250114
88300afc-e1c4-ad17-c80b-4957f1b809a5Product name520250113
4eddd6ca-259a-4c6c-a3a4-2025015ce043Product name720240611
16cde546-8deb-4df2-a072-dab5566ede95Product name120231003
20ab58de-c64a-4ec2-9210-3aa3fae2b66fProduct name120230808
a3631b20-02d1-41d7-8187-5e5e850b9e80Product name120230306
79e1734e-f721-4d46-978a-be382f771672Product name220230110
41b814f3-0166-1c53-c9ef-a0794c7daf9dProduct name320221110
a590be26-846c-8659-a5a1-fb25907965dcProduct name220221110
06cc817f-60e0-4473-8e6b-c44d11dc5af6Product name920220921
92ead9ae-674d-4eee-a492-c385d496891fProduct name320220308
d7724692-1155-4cc8-a415-22f5fc4aec35Product name620220216
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
bde672ba-4805-28d0-1986-73543d41b412Product name220210201
2dc76302-91c0-4c35-ad78-99adfb049c4bProduct name120200603
103b151b-b17f-42ac-8624-3ef62f5e2975Product name220200507
b8497372-efe9-9dde-fa2d-59be9761aa64Product name920200428
20c8cafe-5cfc-44f8-a9be-a664f437f780Product name220200225
3a16d77a-e865-468a-aedf-6e58913c1c21Product name320190619
2a0c98e1-033f-4e0d-a0da-b5291ffbe880Product name120190320
00d531e4-b130-8c52-eaf9-826cbb6f15ddProduct name320190205
aa0f353d-f35e-62e4-4e1f-5b563f01c659Product name920190205
22d922aa-c443-d9f3-b23c-03b03a9ad31cProduct name720181220
e6065d4b-5ae1-476f-a40e-f2851cbb5d2bProduct name220180221
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
377068df-225f-7318-a910-a1987cdfa361Product name320170608
f212291f-05fe-9603-fc7e-bd73e38ce1e6Product name220161129
ade821ba-260a-47e2-bd89-743e27ac9906Product name120161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550Product name220151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657Product name120150929
23475c0b-a5b5-4fec-b97f-acca901eae6aProduct name120140718
105ef617-6fa4-6713-326f-72ec8a6b75a9Product name120140508
2a21311a-89e2-0e83-2ebd-117f9798b2b2Product name120140508
332e86c3-7875-ca6e-f934-2206d2b31996Product name120140508
3ed6b849-48b8-8899-c288-6eeb396123b6Product name120140508
47fd879b-91c5-e1e5-130f-29d082a871ecProduct name120140508
53855190-7124-8179-f018-e792f7c27f28Product name120140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21Product name120140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092Product name120140508
84fb0b3d-1d72-b672-bc70-2b676a23e7e0Product name120140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94eProduct name120140508
96c2be53-8e44-452d-56a2-d255b2f1af2dProduct name120140508
96c5169b-5b9d-547d-bf22-d688d91866e4Product name120140508
b8e0daf1-fb81-290b-c0bf-873be19ef775Product name120140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44Product name120140508
c35d1ac8-8885-2ee1-6c52-5a715b242c00Product name120140508
c8753a88-edde-8e17-a396-705537b52ceeProduct name120140508
cd4f9ae2-1343-ecd2-ce0f-97db0c2b51ceProduct name120140508
cf3a804d-0326-aa22-0142-c184b5657d85Product name120140508
d223c173-c39b-d764-47d4-d671d3088815Product name120140508
d83c592c-dd97-4cbf-36ac-13da806684bdProduct name120140508
e01133ad-4dcd-c7f3-454b-2ff569ee160aProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
0067-2039-022023-05-03Drug Facts
0067-2039-072023-05-03Drug Facts
0067-2039-082023-05-03Drug Facts
0067-2039-092023-05-03Drug Facts
0067-2039-242023-05-03Drug Facts
0067-2039-302023-05-03Drug Facts
0067-2039-332023-05-03Drug Facts
0067-2039-502023-05-03Drug Facts
0067-2039-772023-05-03Drug Facts
0067-2039-832023-05-03Drug Facts
0067-2039-842023-05-03Drug Facts
0067-2039-862023-05-03Drug Facts
0067-2039-912023-05-03Drug Facts
0067-2039-922023-05-03Drug Facts
0067-2039-942023-05-03Drug Facts
0067-2039-022022-07-29Drug Facts
0067-2039-072022-07-29Drug Facts
0067-2039-082022-07-29Drug Facts
0067-2039-092022-07-29Drug Facts
0067-2039-242022-07-29Drug Facts
0067-2039-302022-07-29Drug Facts
0067-2039-332022-07-29Drug Facts
0067-2039-502022-07-29Drug Facts
0067-2039-772022-07-29Drug Facts
0067-2039-832022-07-29Drug Facts
0067-2039-842022-07-29Drug Facts
0067-2039-862022-07-29Drug Facts
0067-2039-912022-07-29Drug Facts
0067-2039-922022-07-29Drug Facts
0067-2039-942022-07-29Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0067-2039-02EXCEDRINMIGRAINE2 in 1 POUCHTABLET, FILM COATED214
0067-2039-07EXCEDRINMIGRAINE250 in 1 BOTTLETABLET, FILM COATED25014
0067-2039-08EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-08EXCEDRINMIGRAINE8 in 1 BOTTLETABLET, FILM COATED814
0067-2039-09EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-09EXCEDRINMIGRAINE10 in 1 BOTTLETABLET, FILM COATED1014
0067-2039-24EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-24EXCEDRINMIGRAINE24 in 1 BOTTLETABLET, FILM COATED2414
0067-2039-30EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-30EXCEDRINMIGRAINE30 in 1 BOTTLETABLET, FILM COATED3014
0067-2039-33EXCEDRINMIGRAINE300 in 1 BOTTLETABLET, FILM COATED30014
0067-2039-33EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-50EXCEDRINMIGRAINE50 in 1 BOTTLETABLET, FILM COATED5014
0067-2039-50EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-77EXCEDRINMIGRAINE250 in 1 BOTTLETABLET, FILM COATED25014
0067-2039-77EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-83EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-83EXCEDRINMIGRAINE125 in 1 BOTTLETABLET, FILM COATED12514
0067-2039-84EXCEDRINMIGRAINE125 in 1 BOTTLETABLET, FILM COATED12514
0067-2039-86EXCEDRINMIGRAINE125 in 1 BOTTLETABLET, FILM COATED12514
0067-2039-86EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-91EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-91EXCEDRINMIGRAINE100 in 1 BOTTLETABLET, FILM COATED10014
0067-2039-92EXCEDRINMIGRAINE1 in 1 CARTONTABLET, FILM COATED114
0067-2039-92EXCEDRINMIGRAINE200 in 1 BOTTLETABLET, FILM COATED20014
0067-2039-94EXCEDRINMIGRAINE100 in 1 BOTTLETABLET, FILM COATED10014

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0067-2039-08EA - Each0067-203916ce8a4b-bd70-4a64-ad07-8ff387eb663812012-07-24
0067-2039-24EA - Each0067-2039bbb39c99-180a-437a-85d0-e53a1eb91ead12012-07-24
0067-2039-33EA - Each0067-20397b55aa5b-c0f7-4ea7-b9a8-55228dc5e47412014-09-03
0067-2039-50EA - Each0067-203922e8dd78-54d4-44ec-a754-b64ce6da0b2712012-07-24
0067-2039-77EA - Each0067-2039e7beb6f2-112b-44d1-bc0c-8cc04775044112012-07-24
0067-2039-83EA - Each0067-2039aeb6329a-c0f6-4dbe-89e3-ff583f2b8adc12024-04-05
0067-2039-86EA - Each0067-2039dfab005f-c6a2-4e68-af6a-5340d2fe2e8312015-10-02
0067-2039-91EA - Each0067-2039baa7e6be-1a22-4946-bd6d-398153fc039712012-07-24
0067-2039-92EA - Each0067-2039517a3c30-8e99-41dd-8798-e5871b87f0ac12015-02-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
ASPIRINACTIVE INGREDIENTR16CO5Y76EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
CAFFEINEACTIVE INGREDIENT3G6A5W338EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
ACETAMINOPHENACTIVE MOIETY362O9ITL9DEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
ASPIRINACTIVE MOIETYR16CO5Y76EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
CAFFEINEACTIVE MOIETY3G6A5W338EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
BENZOIC ACIDINACTIVE INGREDIENT8SKN0B0MIMEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
LIGHT MINERAL OILINACTIVE INGREDIENTN6K5787QVPEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YHEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
POVIDONESINACTIVE INGREDIENTFZ989GH94EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3EXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
SORBITAN MONOLAURATEINACTIVE INGREDIENT6W9PS8B71JEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [NOVARTIS CONSUMER HEALTH, INC.]6
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
ASPIRINACTIVE INGREDIENTR16CO5Y76EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CAFFEINEACTIVE INGREDIENT3G6A5W338EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
ASPIRINACTIVE MOIETYR16CO5Y76EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CAFFEINEACTIVE MOIETY3G6A5W338EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
BENZOIC ACIDINACTIVE INGREDIENT8SKN0B0MIMEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671PEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
LIGHT MINERAL OILINACTIVE INGREDIENTN6K5787QVPEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YHEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
POVIDONEINACTIVE INGREDIENTFZ989GH94EEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3EXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
SORBITAN MONOLAURATEINACTIVE INGREDIENT6W9PS8B71JEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPEXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0067-2039EXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE) TABLET, FILM COATED [HALEON US HOLDINGS LLC]13Current NDC, Legacy NDC, 26 package rows20240407_7ed841fb-a61c-4868-b4e5-4f2311a5e79c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Excedrin MigraineACETAMINOPHEN, ASPIRIN, AND CAFFEINESelect Consumer Group3caa4adf-abe3-67c3-e063-6294a90a87a42026-07-03WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Excedrin MigraineACETAMINOPHEN, ASPIRIN, AND CAFFEINENavajo Manufacturing Company Inc.4efbd21b-92fe-96a7-e063-6294a90ac4ad2026-04-08WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
EXCEDRIN MIGRAINEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEHaleon US Holdings LLC7ed841fb-a61c-4868-b4e5-4f2311a5e79c2025-06-25WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
ndc (product): 0067-2039
Excedrin Migraine ReliefACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINEHaleon US Holdings LLCdd85f3a7-f4d2-4ea0-a7b6-18ebc0e993d82025-03-11WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Excedrin MigraineACETAMINOPHEN, ASPIRIN, AND CAFFEINEHaleon US Holdings LLC910d7254-d0f4-4c5c-a26e-7f8acecbe02d2025-03-11WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Excedrin Extra Strength HeadacheACETAMINOPHEN, ASPIRIN, CAFFEINEJC World Bell Wholesale Co., Inc29b764c7-3d07-5191-e063-6294a90a9c302024-12-23WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Excedrin Migraine, TRAVEL BASIXACETAMINOPHEN, ASPIRIN, AND CAFFEINELil' Drug Store Products, Inc.40aeb2c5-a37b-446d-9918-8378a75ff3272024-12-13WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Excedrin MigraineACETAMINOPHEN, ASPIRIN, AND CAFFEINEA-S Medication Solutionsd012ed1d-b256-48ec-b988-f226c2c5ae9e2024-05-29WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
EXCEDRIN MIGRAINEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEHaleon US Holdings LLC920c8898-e222-4b91-afc5-04d25317ade72024-03-14WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Excedrin Migraine GeltabsACETAMINOPHEN, ASPRIN, CAFFEINEHaleon US Holdings LLCcc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff82024-01-28WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802
Headache Relief Extra StrengthACETAMINOPHEN, ASPIRIN AND CAFFEINEAllegiant Health6197eff5-0351-42ef-bb3f-cbc26e6d0d142018-12-28WarningsExact identifier
application applno (NDA): 020802
application number: NDA020802

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
308297acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral TabletPSN7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
209468EXCEDRIN 250 MG / 250 MG / 65 MG Oral TabletPSN7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
209468acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin]SBD7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
308297acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral TabletSCD7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
308297APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral TabletSY7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
209468APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin]SY7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
209468Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
209468Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
209468Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY7ed841fb-a61c-4868-b4e5-4f2311a5e79c14
308297acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral TabletPSN540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
209468EXCEDRIN 250 MG / 250 MG / 65 MG Oral TabletPSN540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
209468acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin]SBD540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
308297acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral TabletSCD540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
308297APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral TabletSY540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
209468APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin]SY540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
209468Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
209468Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1
209468Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral TabletSY540c34a3-a4dc-4dd7-8ef9-53092b7a86bb1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0067-2039-02000672039022 TABLET, FILM COATED in 1 POUCH (0067-2039-02) 2010-02-150000-00-00NoNoCurrent
0067-2039-0700067203907250 in 1 BOTTLEHistorical
0067-2039-08000672039081 in 1 CARTONHistorical
0067-2039-09000672039091 in 1 CARTONHistorical
0067-2039-24000672039241 BOTTLE in 1 CARTON (0067-2039-24) / 24 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-30000672039301 BOTTLE in 1 CARTON (0067-2039-30) / 30 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-33000672039331 BOTTLE in 1 CARTON (0067-2039-33) / 300 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-50000672039501 BOTTLE in 1 CARTON (0067-2039-50) / 50 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-77000672039771 BOTTLE in 1 CARTON (0067-2039-77) / 250 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-83000672039831 BOTTLE in 1 CARTON (0067-2039-83) / 125 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-8400067203984125 in 1 BOTTLEHistorical
0067-2039-8600067203986125 in 1 BOTTLEHistorical
0067-2039-91000672039911 BOTTLE in 1 CARTON (0067-2039-91) / 100 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-92000672039921 BOTTLE in 1 CARTON (0067-2039-92) / 200 TABLET, FILM COATED in 1 BOTTLE1 bottle2010-02-150000-00-00NoNoCurrent
0067-2039-9400067203994100 in 1 BOTTLEHistorical